Brain signalling systems: A target for treating type I diabetes mellitus. Keywords : ['brain signal system', 'treat type', 'diabetes mellitus', 'target'] Author : R Ramakrishnan 4
Residual vascular risk in diabetes - Will the SPPARM alpha concept hold the key? Keywords : ['spparm alpha concept hold', 'residual vascular risk', 'key', 'diabetes'] Author : JC Fruchart 4
Residual vascular risk in diabetes - Will the SPPARM alpha concept hold the key? Keywords : ['spparm alpha concept hold', 'residual vascular risk', 'key', 'diabetes'] Author : JC Fruchart 4
Active-site environment of Cu bound amyloid beta and amylin peptides. Keywords : ['cu bind amyloid beta', 'amylin peptide', 'activesite environment'] Author : I Pal 4
Active-site environment of Cu bound amyloid beta and amylin peptides. Keywords : ['cu bind amyloid beta', 'amylin peptide', 'activesite environment'] Author : I Pal 4
Synthetic strategy and SAR studies of C-glucoside heteroaryls as SGLT2 inhibitor: A review. Keywords : ['synthetic strategy', 'sar study', 'cglucoside heteroaryls', 'review', 'inhibitor'] Author : K Haider 4
Synthetic strategy and SAR studies of C-glucoside heteroaryls as SGLT2 inhibitor: A review. Keywords : ['synthetic strategy', 'sar study', 'cglucoside heteroaryls', 'review', 'inhibitor'] Author : K Haider 4
Synthetic strategy and SAR studies of C-glucoside heteroaryls as SGLT2 inhibitor: A review. Keywords : ['synthetic strategy', 'sar study', 'cglucoside heteroaryls', 'review', 'inhibitor'] Author : K Haider 4
Synthetic strategy and SAR studies of C-glucoside heteroaryls as SGLT2 inhibitor: A review. Keywords : ['synthetic strategy', 'sar study', 'cglucoside heteroaryls', 'review', 'inhibitor'] Author : K Haider 4
Synthetic strategy and SAR studies of C-glucoside heteroaryls as SGLT2 inhibitor: A review. Keywords : ['synthetic strategy', 'sar study', 'cglucoside heteroaryls', 'review', 'inhibitor'] Author : K Haider 4
